Cacquevel M, Aeschbach L, Houacine J, Fraering PC.
Alzheimer's disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified γ-secretase complexes.
PLoS One. 2012;7(4):e35133.
Please login to recommend the paper.
To make a comment you must login or register.
If it turns out that FAD mutations are generally loss of function, then the phenotype of haploinsufficiency would be the same as partial inhibition with γ-secretase inhibitors. Is this is why γ-secretase inhibitors failed in Phase 3? Maybe degrading APPβ CTF is a good thing?